ARCHIVES

In Brief: FDA Changes Package Inserts For Thiotepa, Cyclophosphamide, As Committee Suggested

This article is from The Cancer Letter archive.

Vol. 05 No. 35 | August 31, 1979

Download PDF Visit The Full Archive

Related Articles

Also New AACR President Lynn Matrisian plans emphasis on enhancing communication.

April 2, 2004

Growth in Research Capacity Explains Increased Competition, NIH Director Tells NCAB.

June 16, 2006

FDA orders “limited distribution” for lung cancer drug Iressa.

June 24, 2005

ONS Continue Growth, Associate Category Defeated Again

May 15, 1987

Advisors’ Report On Intramural Program To Recommend Restructuring

April 14, 1995

In Brief: Carcinogenesis Task Force to Wrap Up Review In Four-Six Weeks; UCLA Groundbreaking Set

October 28, 1977